Nova Biopharma

Nova Biopharma is a specialty pharmaceutical company headquartered in Dubai, United Arab Emirates, focused on the Middle East and North Africa (MENA) region. The company serves as a strategic commercialization and market access partner for global biotechnology and pharmaceutical firms, facilitating the entry of innovative therapies into regional markets. Nova Biopharma provides a comprehensive suite of services, including regulatory affairs, medical affairs, pricing, and specialized distribution. Their portfolio focuses on high-unmet-need areas such as oncology, rare diseases, and hematology, representing products from international partners such as Incyte, Agios, and Seagen. By bridging the gap between global innovation and regional healthcare needs, the company ensures that patients in the MENA region have access to cutting-edge medical treatments.